title: Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
authors.affiliation: Department of Surgery, State University of New York Health Science Center at Brooklyn 11203, USA.
authors.forename: N
authors.initials: N
authors.lastname: Sumrani
authors.forename: J H
authors.initials: JH
authors.lastname: Hong
authors.forename: A
authors.initials: A
authors.lastname: DiBenedetto
authors.forename: R
authors.initials: R
authors.lastname: Clayton
authors.forename: A M
authors.initials: AM
authors.lastname: Miles
authors.forename: M S
authors.initials: MS
authors.lastname: Markell
authors.forename: D A
authors.initials: DA
authors.lastname: Distant
authors.forename: J
authors.initials: J
authors.lastname: Fleishhacker
authors.forename: B G
authors.initials: BG
authors.lastname: Sommer
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001706:Biopsy; D001803:Blood Transfusion; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000473:pathology / Q000628:therapy; D006085:Graft Survival / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D003404:Creatinine; D008775:Methylprednisolone